BE763725A - - Google Patents

Info

Publication number
BE763725A
BE763725A BE763725A BE763725A BE763725A BE 763725 A BE763725 A BE 763725A BE 763725 A BE763725 A BE 763725A BE 763725 A BE763725 A BE 763725A BE 763725 A BE763725 A BE 763725A
Authority
BE
Belgium
Application number
BE763725A
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BE763725A publication Critical patent/BE763725A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • C07C279/26X and Y being nitrogen atoms, i.e. biguanides
BE763725A 1970-03-03 1971-03-03 BE763725A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702009743 DE2009743A1 (de) 1970-03-03 1970-03-03 Substituierte Biguanide mit antihyperglykämischer Wirkung

Publications (1)

Publication Number Publication Date
BE763725A true BE763725A (xx) 1971-09-03

Family

ID=5763819

Family Applications (1)

Application Number Title Priority Date Filing Date
BE763725A BE763725A (xx) 1970-03-03 1971-03-03

Country Status (11)

Country Link
AT (1) AT302350B (xx)
BE (1) BE763725A (xx)
CH (2) CH553756A (xx)
DE (1) DE2009743A1 (xx)
ES (2) ES388863A1 (xx)
FR (1) FR2085665B1 (xx)
GB (1) GB1343831A (xx)
IE (1) IE34966B1 (xx)
IL (1) IL36271A0 (xx)
NL (1) NL7102612A (xx)
ZA (1) ZA711269B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064664C (en) * 1991-04-05 2000-01-11 Hiroshi Ishikawa Biguanide derivatives, manufacturing method thereof, and disinfectants containing the derivatives
DE122010000020I1 (de) 1996-04-25 2010-07-08 Prosidion Ltd Verfahren zur Senkung des Blutglukosespiegels in Säugern
DE19828114A1 (de) 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19828113A1 (de) 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19834591A1 (de) 1998-07-31 2000-02-03 Probiodrug Ges Fuer Arzneim Verfahren zur Steigerung des Blutglukosespiegels in Säugern
DE19926233C1 (de) 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Verfahren zur Herstellung von Thiazolidin
EP2055302B1 (en) 2000-03-31 2014-09-10 Royalty Pharma Collection Trust Method for the improvement of islet signaling in diabetes mellitus and for its prevention
US7132104B1 (en) 2000-10-27 2006-11-07 Probiodrug Ag Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
FR2822464B1 (fr) * 2001-03-21 2004-08-06 Lipha Derives biguanides et leurs applications en therapeutique
US6890905B2 (en) 2001-04-02 2005-05-10 Prosidion Limited Methods for improving islet signaling in diabetes mellitus and for its prevention
US7368421B2 (en) 2001-06-27 2008-05-06 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
DE10150203A1 (de) 2001-10-12 2003-04-17 Probiodrug Ag Peptidylketone als Inhibitoren der DPIV
US20030130199A1 (en) 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
SK3622004A3 (sk) 2002-02-28 2005-02-04 Prosidion Limited Inhibítory DPIV na báze glutaminylu
JP2005522495A (ja) 2002-04-11 2005-07-28 カルボマー インク 新規な糖尿病イメージングプローブ
CN101837127A (zh) 2003-05-05 2010-09-22 前体生物药物股份公司 谷氨酰胺酰基和谷氨酸环化酶效应物的应用
DE602004026289D1 (de) 2003-05-05 2010-05-12 Probiodrug Ag Glutaminylcyclase-hemmer
AU2005210004B2 (en) 2004-02-05 2010-10-28 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
CN110615886A (zh) * 2019-09-05 2019-12-27 哈尔滨工程大学 一种双胍衍生物抗菌型环氧树脂固化剂及其制备方法
CN115960018B (zh) * 2022-12-19 2024-01-05 湖南岳靶生物医药有限公司 一种egfr抑制剂、组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR940304A (fr) * 1946-01-07 1948-12-09 Ici Ltd Procédé de fabrication de dérivés de biguanides
FR1053761A (fr) * 1949-01-31 1954-02-04 Ici Ltd Fabrication de dérivés de la biguanide
BE612641A (xx) * 1961-01-18
FR6786M (xx) * 1967-08-10 1969-03-17

Also Published As

Publication number Publication date
GB1343831A (en) 1974-01-16
IE34966L (en) 1971-09-03
ES388863A1 (es) 1973-06-01
AT302350B (de) 1972-10-10
DE2009743A1 (de) 1971-09-16
IL36271A0 (en) 1971-04-28
ZA711269B (en) 1971-11-24
FR2085665A1 (xx) 1971-12-31
ES391629A1 (es) 1974-09-16
CH564526A5 (xx) 1975-07-31
IE34966B1 (en) 1975-10-01
CH553756A (de) 1974-09-13
NL7102612A (xx) 1971-09-07
FR2085665B1 (xx) 1974-08-30

Similar Documents

Publication Publication Date Title
AR204384A1 (xx)
FR2085665B1 (xx)
USB403243I5 (xx)
ATA96471A (xx)
AU2044470A (xx)
AU1146470A (xx)
AU1336970A (xx)
AU2017870A (xx)
AU2085370A (xx)
AU2130570A (xx)
AU1247570A (xx)
AU1591370A (xx)
AU1881070A (xx)
AU1235770A (xx)
AU1943370A (xx)
AU1343870A (xx)
AU1189670A (xx)
AU1969370A (xx)
ATA672271A (xx)
AU1974970A (xx)
AU1277070A (xx)
AU1064870A (xx)
AU1328670A (xx)
AU2061170A (xx)
AU2144270A (xx)